ANTISEIZURE remedy use throughout being pregnant was related to variations in foetal growth, with dangers various by remedy routine and particular person medication, in response to a big potential worldwide cohort examine.
Polytherapy Related with Larger Progress Danger
The examine analysed 15,893 offspring uncovered to antiseizure medicines throughout being pregnant, together with 12,911 uncovered to monotherapy and a couple of,982 uncovered to polytherapy. The researchers examined birthweight centile as the first final result, alongside small for gestational age, extreme small for gestational age and low birthweight.
In contrast with monotherapy, prenatal publicity to polytherapy was related to a decrease birthweight centile and roughly 50% increased odds of a number of measures of poor foetal progress. The adjusted odds ratio for small for gestational age was 1.48 (95% CI: 1.29–1.70), whereas the corresponding estimates had been 1.49 (95% CI: 1.22–1.83) for extreme small for gestational age and 1.50 (95% CI: 1.15–1.95) for low birthweight.
The affiliation additionally appeared to strengthen because the variety of concomitant antiseizure medicines elevated. Among the many small group uncovered to 4 medicines, birthweight centile was considerably decrease than amongst these receiving monotherapy.
Variations Recognized Between Particular person Medicines
The evaluation additionally discovered variation between antiseizure remedy monotherapies. In contrast with lamotrigine, birthweight centile was decrease amongst offspring uncovered to topiramate, phenobarbital, oxcarbazepine, carbamazepine, valproic acid and levetiracetam.
The most important distinction was noticed with topiramate, which was related to an adjusted birthweight centile coefficient of −11.93 (95% CI: −16.72 to −7.15). Decrease birthweight centiles had been additionally related to phenobarbital, oxcarbazepine, carbamazepine, valproic acid and levetiracetam.
Nevertheless, the findings weren’t uniform throughout combos. Offspring uncovered to carbamazepine and levetiracetam collectively had a decrease birthweight centile than these uncovered to lamotrigine monotherapy, whereas no distinction was recognized between lamotrigine alone and lamotrigine mixed with both levetiracetam or valproic acid.
Implications For Being pregnant Administration
The researchers mentioned poor foetal progress needs to be thought-about alongside congenital malformations and neurodevelopmental results when assessing the potential opposed outcomes related to prenatal antiseizure remedy publicity.
The findings might have implications for preconception counselling and remedy choice, notably when contemplating the quantity and mixture of antiseizure medicines required to manage epilepsy throughout being pregnant.
Importantly, the observational design means the findings determine associations moderately than establishing that particular person medicines instantly precipitated poor foetal progress. The researchers concluded that danger prediction and remedy choice ought to account for variations between particular person antiseizure medicines and combos, supporting a extra individualised strategy to managing epilepsy throughout being pregnant.
Reference
Perucca P et al.; EURAP Collaborators. Antiseizure remedy use in being pregnant and the chance of poor fetal progress within the EURAP worldwide registry: a potential cohort examine. Lancet Neurol. 2026;25(9):8
Featured Picture: Zffoto on Adobe Inventory
